Changes in biomarkers of estrogen receptor and growth factor signaling pathways in MCF-7 tumors after short- and long-term treatment with soy and flaxseed

Journal of Steroid Biochemistry and Molecular Biology

Volumn 112, Issue 1-3, 2008, Pages 13-19

  Power, Krista A ^a   Chen, Jian Min ^a   Saarinen, Niina M ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biomarkers; Flaxseed; MCF 7 xenografts; Soy protein

Indexed keywords

BIOLOGICAL MARKER; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GROWTH FACTOR; KI 67 ANTIGEN; LINSEED OIL; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LINSEED; LONG TERM EXPOSURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOYBEAN; TUMOR GROWTH; TUMOR PROMOTION; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; FEMALE; FLAX; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OVARIECTOMY; PLANT PREPARATIONS; RECEPTOR, IGF TYPE 1; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; SOYBEAN PROTEINS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

MUS;

EID: 55349133777     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.07.003     Document Type: Article

References (26)

1. Wakeling A.E., and Bowler J. ICI 182 780, a new antioestrogen with clinical potential. J. Steroid Biochem. Mol. Biol. 43 1-3 (1992) 173-177
2. Saarinen N.M., Power K.A., Chen J., and Thompson L.U. Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts. Int. J. Cancer 119 4 (2006) 925-931
3. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., and Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 10 (1998) 4252-4263
4. Mueller S.O., Simon S., Chae K., Metzler M., and Korach K.S. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol. Sci. 80 1 (2004) 14-25
5. Penttinen P., Jaehrling J., Damdimopoulos A.E., Inzunza J., Lemmen J.G., van der Saag P., Pettersson K., Gauglitz G., Mäkelä S., and Pongratz I. Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 148 10 (2007) 4875-4886
6. Carreau C., Flouriot G., Bennetau-Pelissero C., and Potier M. Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERα transcriptional activation in human breast cancer cells. J. Steroid Biochem. Mol. Biol. 110 1-2 (2008) 176-185
7. Gutierrez M.C., Detre S., Johnston S., Mohsin S.K., Shou J., Allred D.C., Schiff R., Osborne C.K., and Dowsett M. Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. J. Clin. Oncol. 23 11 (2005) 2469-2476
8. Santen R.J., Song R.X., Zhang Z., Kumar R., Jeng M.H., Masamura A., Lawrence Jr. J., Berstein L., and Yue W. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity. Endocr. Rel. Cancer 12 Suppl. 1 (2005) S61-S73
9. Lehnes K., Winder A.D., Alfonso C., Kasid N., Simoneaux M., Summe H., Morgan E., Iann M.C., Duncan J., Eagan M., Tavaluc R., Evans Jr. C.H., Russell R., Wang A., Hu F., and Stoica A. The effect of estradiol on in vivo tumorigenesis is modulated by the human epidermal growth factor receptor 2/phosphatidylinositol 3-kinase/Akt1 pathway. Endocrinology 148 3 (2007) 1171-1180
10. Chen W.F., Gao Q.G., and Wong M.S. Mechanism involved in genistein activation of insulin-like growth factor 1 receptor expression in human breast cancer cells. Br. J. Nutr. 98 6 (2007) 1120-1125
11. Tsai M., and O'Malley B. Molecular mechanisms of action of steroid/thyroid receptor superfamily. Annu. Rev. Biochem. 63 (1994) 451-486
12. Bjornstrom L., and Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 19 4 (2005) 833-842
13. Osborne C.K., and Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J. Clin. Oncol. 23 8 (2005) 1616-1622
14. Santen R.J., Song R.X., McPherson R., Kumar R., Adam L., Jeng M.H., and Yue W. The role of mitogen-activated protein (MAP) kinase in breast cancer. J. Steroid Biochem. Mol. Biol. 80 2 (2002) 239-256
15. Likhite V.S., Stossi F., Kim K., Katzenellenbogen B.S., and Katzenellenbogen J.A. Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity. Mol. Endocrinol. 20 12 (2006) 3120-3132
16. Chen J., Hui E., Ip T., and Thompson L.U. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (MCF-7) in nude mice. Clin. Cancer Res. 10 22 (2004) 7703-7711
17. Power K.A., Saarinen N.M., Chen J.M., and Thompson L.U. Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice. Int. J. Cancer 118 5 (2006) 1316-1320
18. Canadian Council on Animal Care, Guide to the Care and Use of Experimental Animals, vol. 2, 1984.
19. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123 11 (1993) 1939-1951
20. Allred D.C., Harvey J.M., Berardo M., and Clark G.M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod. Pathol. 11 2 (1998) 155-168
21. Pettersson K., Delaunay F., and Gustafsson J.A. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 19 43 (2000) 4970-4978
22. Horwitz K.B., Koseki Y., and McGuire W.L. Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology 103 5 (1978) 1742-1751
23. Allred C.D., Allred K.F., Ju Y.H., Goeppinger T.S., Doerge D.R., and Helferich W.G. Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 25 9 (2004) 1649-1657
24. Welshons W., Murphy C., Koch R., Calaf G., and Jordan V. Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res. Treat. 10 2 (1987) 169-175
25. Chen J., Stavro P.M., and Thompson L.U. Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr. Cancer 43 2 (2002) 187-192
26. Thompson L.U., Chen J.M., Li T., Strasser-Weippl K., and Goss P.E. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin. Cancer Res. 11 10 (2005) 3828-3835